Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Irinotecan + l-Leucovorin + 5-FU in Advanced Colorectal Cancer
NCT00209625Phase 2Completed
- Sponsor
- Hokkaido Gastrointestinal Cancer Study Group
- Start
- Apr 2000
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of irinotecan in colorectal cancer (CRC), sponsored by Hokkaido Gastrointestinal Cancer Study Group. Primary endpoint: Objective Tumor Response. Started Apr 2000; status: completed.
02
Drugs
irinotecan
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00209625.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00209625.